![Brendan Eckelman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brendan Eckelman
Plus aucun poste en cours
Profil
Brendan P.
Eckelman was the founder of Inhibrx LP, serving as Vice President-Scientific Operations since 2010 until 2014.
Dr. Eckelman was the founder of Inhibrx, Inc., serving as Chief Scientific Officer from 2021 to 2024.
Dr. Eckelman was the founder of Inhibrx Biosciences, Inc., serving as Chief Scientific Officer & Executive VP from 2024 to 2025.
Former job includes Research Investigator at Novartis Institute for Functional Genomics, Inc. Education includes undergraduate and graduate degrees from the University of California San Diego and a doctorate from UC San Diego School of Medicine.
Anciens postes connus de Brendan Eckelman
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBRX, INC. | Fondateur | 30/05/2024 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | - |
Inhibrx LP
 Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Fondateur | - |
Formation de Brendan Eckelman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Develops therapeutic antibodies and pharmaceuticals | Health Technology |
UC San Diego School of Medicine
 UC San Diego School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
